Association between topical β-blocker use and asthma attacks in glaucoma patients with asthma: a cohort study using a claims database

Author:

Kido Ai,Miyake Masahiro,Akagi Tadamichi,Ikeda Hanako Ohashi,Kameda Takanori,Suda Kenji,Hasegawa Tomoko,Hiragi Shusuke,Yoshida Satomi,Tsujikawa Akitaka,Tamura Hiroshi,Kawakami KojiORCID

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Reference39 articles.

1. Morizane Y, Morimoto N, Fujiwara A, Kawasaki R, Yamashita H, Ogura Y, Shiraga F (2019) Incidence and causes of visual impairment in Japan: the first nation-wide complete enumeration survey of newly certified visually impaired individuals. Jpn J Ophthalmol 63:26–33. https://doi.org/10.1007/s10384-018-0623-4

2. Flaxman SR, Bourne RRA, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, Das A, Jonas JB, Keeffe J, Kempen JH, Leasher J, Limburg H, Naidoo K, Pesudovs K, Silvester A, Stevens GA, Tahhan N, Wong TY, Taylor HR, Vision Loss Expert Group of the Global Burden of Disease Study (2017) Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis. Lancet Glob Health 5:e1221–e1234

3. Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY (2014) Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121:2081–2090. https://doi.org/10.1016/j.ophtha.2014.05.013

4. Garway-Heath DF, Lascaratos G, Bunce C, Crabb DP, Russell RA, Shah A, United Kingdom Glaucoma Treatment Study Investigators (2013) The United Kingdom Glaucoma Treatment Study: a multicenter, randomized, placebo-controlled clinical trial: design and methodology. Ophthalmology 120:68–76. https://doi.org/10.1016/j.ophtha.2012.07.028

5. Ismail R, Azuara-Blanco A, Ramsay CR (2014) Variation of clinical outcomes used in glaucoma randomised controlled trials: a systematic review. Br J Ophthalmol 98:464–468. https://doi.org/10.1136/bjophthalmol-2013-304323

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3